Development of the polymer micelle carrier system for doxorubicin

被引:455
作者
Nakanishi, T
Fukushima, S
Okamoto, K
Suzuki, M
Matsumura, Y
Yokoyama, M
Okano, T
Sakurai, Y
Kataoka, K
机构
[1] Nippon Kayaku Co Ltd, Drug Res Dept, Kita Ku, Tokyo 1158588, Japan
[2] Natl Canc Ctr Hosp, Dept Med, Chuo Ku, Tokyo 1040045, Japan
[3] Tokyo Womens Med Univ, Inst Biomed Engn, Shinjyuku Ku, Tokyo 1620054, Japan
[4] Univ Tokyo, Dept Mat Sci, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan
关键词
doxorubicin; anticancer drug; drug targeting; polymeric micelle;
D O I
10.1016/S0168-3659(01)00341-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We show the result of pre-clinical study of NK911, a polymeric micelle carrier system for doxorubicin (DOX). The NK911 micelle carrier consists of polyethyleneglycol and conjugated doxorubicin-polyaspartic acid. It has high hydrophobic inner core, and therefore can entrap the sufficient amount of DOX. NK911 has a small particle size of about 40 nm in diameter that accumulates in tumor tissue by EPR effect showing much stronger activity than the free DOX. We plan to perform a clinical trial at National Cancer Center Hospital, Japan from 2001. (C) 2001 Elsevier Science BY. All rights reserved.
引用
收藏
页码:295 / 302
页数:8
相关论文
共 12 条